News

Researchers have found a neural home for the feeling of stress, which could provide insight into how the feeling can be dealt with.

Nearly half of individuals who contract COVID-19 experience an abnormal or complete loss of their sense of taste, a new analysis has found.

A team of researchers led by Swansea University have developed new technology to monitor cholesterol in brain tissue which could uncover its relation to neurodegenerative disease and pave the way for the development of new treatments.

Researchers have identified a new genomic region and anxiety-related candidate genes associated with fearfulness in dogs.

High-throughput analysis of blood plasma could aid in the identification of diagnostic and prognostic biomarkers for ALS, according to a new study.

The anesthetic drug ketamine administered in low doses, has been shown to help treat difficult-to-treat depression. A research team has now identified a key target for the drug – specific serotonin receptors in the brain.

Researchers have solved the longstanding mystery of the mechanisms behind the effects of anesthetics.

Molecules released into the blood following mild traumatic brain injury may be indicators of neuronal damage associated with complications, according to new research.

A team from Duke University has developed a synthetic molecule that selectively dampens the physiological rewards of cocaine in mice. This molecule could represent a new class of drugs that may be more specific that currently available medications, with fewer adverse effects.

A study has discovered two potential candidates to treat Alzheimer’s disease. The two marine molecules, meridianine and lignarenone B, can alter the activity of GSK3B activity, a protein linked to several neurodegenerative diseases.